top
Search terms
Results 1 - 10 of 10 - ordered by :
Ehjcardiovascrec

The antihypertensive drug amlodipine (Norvasc®) is a long-acting, third-generation Ca2+ channel blocker that has been shown to limit the progression of atherosclerosis and to decrease the ...

Cardiovascular Research, Mayer, Bernd

Date : 01/08/2006
Ehjcardiovascrec

In their comment to our recent study on the development of vascular tolerance to nitroglycerin (GTN) upon long-term ascorbate deprivation of guinea pigs,1 Daiber and Gori suggest that our data are in ...

Cardiovascular Research, Mayer, Bernd

Date : 01/09/2008
Ehjcardiovascrec

Abstract Objective:l-Ascorbic acid has been described to exert multiple beneficial effects in cardiovascular disorders associated with impaired nitric oxide (NO)/cGMP signalling. The aim of the ...

Cardiovascular Research, Schrammel, Astrid, Koesling, Doris, Schmidt, Kurt, Mayer, Bernd

Date : 18/08/2000
Ehjcardiovascrec

Abstract Objective: The role of nitric oxide (NO) in myocardial ischemia/reperfusion injury remains controversial as both NO donors and NO synthase (NOS) inhibitors have shown to be ...

Cardiovascular Research, Brunner, Friedrich, Maier, Robert, Andrew, Penelope, Wölkart, Gerald, Zechner, Rudolf, Mayer, Bernd

Date : 01/01/2003 Item size : 279342 bytes
Ehjcardiovascrec

Abstract Aims Nitroglycerin (GTN) acts through release of a nitric oxide (NO)-related activator of soluble guanylate cyclase in vascular smooth muscle. Besides enzymatic GTN bioactivation catalysed ...

Cardiovascular Research, Wölkart, Gerald, Wenzl, M. Verena, Beretta, Matteo, Stessel, Heike, Schmidt, Kurt, Mayer, Bernd

Date : 15/07/2008 Item size : 309056 bytes
Ehjcardiovascrec

Abstract Objectives: We tested the hypothesis that endothelin-1 (ET-1) aggravates ischaemia/reperfusion injury by stimulating cellular L-arginine depletion, which would result in reduced synthesis of ...

Cardiovascular Research, Brunner, Friedrich, Leonhard, Bernhard, Kukovetz, Walter R, Mayer, Bernd

Date : 01/10/1997 Item size : 200475 bytes
Ehjcardiovascrec

Abstract Objective:l-Ascorbic acid has been described to exert multiple beneficial effects in cardiovascular disorders associated with impaired nitric oxide (NO)/cGMP signalling. The aim of the ...

Cardiovascular Research, Schrammel, Astrid, Koesling, Doris, Schmidt, Kurt, Mayer, Bernd

Date : 18/08/2000 Item size : 258939 bytes
Ehjcardiovascrec

The antihypertensive drug amlodipine (Norvasc®) is a long-acting, third-generation Ca2+ channel blocker that has been shown to limit the progression of atherosclerosis and to decrease the ...

Cardiovascular Research, Mayer, Bernd

Date : 01/08/2006 Item size : 135090 bytes
Ehjcardiovascrec

In their comment to our recent study on the development of vascular tolerance to nitroglycerin (GTN) upon long-term ascorbate deprivation of guinea pigs,1 Daiber and Gori suggest that our data are in ...

Cardiovascular Research, Mayer, Bernd

Date : 01/09/2008
Ehjcardiovascrec

Abstract Aims Nitroglycerin (GTN) acts through release of a nitric oxide (NO)-related activator of soluble guanylate cyclase in vascular smooth muscle. Besides enzymatic GTN bioactivation catalysed ...

Cardiovascular Research, Wölkart, Gerald, Wenzl, M. Verena, Beretta, Matteo, Stessel, Heike, Schmidt, Kurt, Mayer, Bernd

Date : 15/07/2008